Skip to main content
. Author manuscript; available in PMC: 2016 Feb 8.
Published in final edited form as: Peptides. 2013 Dec 25;52:104–112. doi: 10.1016/j.peptides.2013.12.010

Fig. 3.

Fig. 3

Impact of GHRH agonists on cardiac function. Bar graphs showing the percentage of change in ejection fraction (EF%) at 4 weeks relative to day 2 post-MI. All values are shown as mean ± SEM (*p < 0.05, †p < 0.01 vs. Placebo, n = 6–12).